Total Payments
$9,677
2024 Payments
$1,832
Companies
31
Transactions
400
Medicare Patients
1,024
Medicare Billing
$78,033
Payment Breakdown by Category
Food & Beverage$9,673 (99.9%)
Education$4.93 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,673 | 399 | 99.9% |
| Education | $4.93 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,585 | 43 | $0 (2024) |
| Novo Nordisk Inc | $1,156 | 74 | $0 (2024) |
| Amgen Inc. | $1,151 | 34 | $0 (2024) |
| Lilly USA, LLC | $956.22 | 46 | $0 (2024) |
| ABBVIE INC. | $903.22 | 47 | $0 (2024) |
| Abbott Laboratories | $440.84 | 13 | $0 (2024) |
| GlaxoSmithKline, LLC. | $416.29 | 16 | $0 (2024) |
| PFIZER INC. | $383.03 | 26 | $0 (2024) |
| Exact Sciences Corporation | $373.44 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $351.16 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,832 | 76 | AstraZeneca Pharmaceuticals LP ($474.81) |
| 2023 | $2,412 | 111 | AstraZeneca Pharmaceuticals LP ($524.78) |
| 2022 | $4,127 | 170 | Amgen Inc. ($588.05) |
| 2021 | $884.94 | 34 | AbbVie Inc. ($164.95) |
| 2020 | $311.28 | 8 | Amgen Inc. ($218.82) |
| 2019 | $110.38 | 1 | Horizon Therapeutics plc ($110.38) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.19 | General |
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: VACCINES | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.00 | General |
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $113.52 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 553 | 728 | $132,172 | $37,468 |
| 2022 | 8 | 299 | 399 | $57,629 | $26,068 |
| 2021 | 6 | 172 | 192 | $22,782 | $14,497 |
Total Patients
1,024
Total Services
1,319
Medicare Billing
$78,033
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 40 | 40 | $26,600 | $11,301 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 347 | $60,725 | $10,425 | 17.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 137 | 137 | $27,811 | $7,056 | 25.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 51 | 51 | $3,417 | $3,349 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 55 | $2,420 | $1,615 | 66.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 43 | $5,389 | $1,397 | 25.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,760 | $1,174 | 66.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,050 | $1,150 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 183 | $30,187 | $11,998 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 53 | 53 | $10,759 | $5,351 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 52 | $6,552 | $2,544 | 38.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $1,876 | $1,837 | 97.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,816 | $1,661 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,060 | $1,296 | 42.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 31 | $1,364 | $868.73 | 63.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 29 | 29 | $1,015 | $512.60 | 50.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 70 | $10,990 | $6,814 | 62.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 28 | 28 | $5,684 | $3,602 | 63.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 25 | $2,650 | $1,709 | 64.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 25 | 25 | $1,675 | $1,632 | 97.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 27 | 27 | $1,188 | $437.13 | 36.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 17 | 17 | $595.00 | $302.77 | 50.9% |
About Dr. Christopher D'amico, DO
Dr. Christopher D'amico, DO is a Family Medicine healthcare provider based in Euclid, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2018. The National Provider Identifier (NPI) number assigned to this provider is 1821585860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher D'amico, DO has received a total of $9,677 in payments from pharmaceutical and medical device companies, with $1,832 received in 2024. These payments were reported across 400 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,673).
As a Medicare-enrolled provider, D'amico has provided services to 1,024 Medicare beneficiaries, totaling 1,319 services with total Medicare billing of $78,033. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Euclid, OH
- Active Since 04/16/2018
- Last Updated 05/01/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821585860
Products in Payments
- Rybelsus (Drug) $594.29
- BREZTRI (Drug) $579.93
- FARXIGA (Drug) $546.58
- NURTEC ODT (Drug) $507.49
- MOUNJARO (Drug) $482.00
- AIRSUPRA (Drug) $458.81
- Repatha (Biological) $455.49
- ELIQUIS (Drug) $404.89
- Cologuard Collection Kit (Device) $373.44
- UBRELVY (Drug) $365.78
- Ozempic (Drug) $311.77
- Otezla (Drug) $295.18
- TRULICITY (Drug) $241.09
- QULIPTA (Drug) $227.01
- SOLIQUA 100/33 (Biological) $208.19
- Aimovig (Biological) $208.03
- XIFAXAN (Drug) $206.33
- SHINGRIX (Biological) $204.70
- EVENITY (Biological) $192.46
- KRYSTEXXA (Biological) $185.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Euclid
George Thomas, Do, DO
Family Medicine — Payments: $28,939
Family Medicine $28,939
Dr. Paul Thomas, D.o, D.O
Family Medicine — Payments: $12,693
Family Medicine $12,693
Dr. Sean Cupp, M.d, M.D
Family Medicine — Payments: $10,953
Family Medicine $10,953
Ms. Cheryl Katz, Md, MD
Family Medicine — Payments: $4,753
Family Medicine $4,753
Anisa Rista, Md, MD
Family Medicine — Payments: $1,959
Family Medicine $1,959
Leandria Tazewell, M.d, M.D
Family Medicine — Payments: $822.51
Family Medicine $822.51